These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. Berger M; Rojavin M; Kiessling P; Zenker O Clin Immunol; 2011 May; 139(2):133-41. PubMed ID: 21353644 [TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986. J Infect; 1987 Jul; 15 Suppl 1():1-65. PubMed ID: 3117895 [No Abstract] [Full Text] [Related]
25. [Effects and side effects of intravenous gamma globulin I: the problem of immune complex formation]. Tilz GP; Nydegger U Wien Med Wochenschr; 1991; 141(13):301-3. PubMed ID: 1926879 [TBL] [Abstract][Full Text] [Related]
26. [Current developments in the use of intravenous immunoglobulins]. Bardare M; Dellepiane RM Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793 [TBL] [Abstract][Full Text] [Related]
27. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Blanchette VS; Kirby MA; Turner C Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297 [TBL] [Abstract][Full Text] [Related]
28. Idiopathic thrombocytopenic purpura and IgG: a review. Newland AC J Infect; 1987 Jul; 15 Suppl 1():41-9. PubMed ID: 3117899 [No Abstract] [Full Text] [Related]
29. Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations. Späth PJ; Schneider C; von Gunten S Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):215-231. PubMed ID: 27638480 [TBL] [Abstract][Full Text] [Related]
30. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies]. Mouthon L; Bussone G; Kaveri S Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651 [TBL] [Abstract][Full Text] [Related]
36. A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency. Wasserman RL Expert Rev Clin Immunol; 2014 Mar; 10(3):325-37. PubMed ID: 24527947 [TBL] [Abstract][Full Text] [Related]
37. Immunoregulation of autoimmune disorders: the role of intravenous immunoglobulins. Luzi G; Ferrara R Int J Artif Organs; 1993 Dec; 16 Suppl 5():189-95. PubMed ID: 8013987 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulins as therapeutic agents. Stiehm ER; Ashida E; Kim KS; Winston DJ; Haas A; Gale RP Ann Intern Med; 1987 Sep; 107(3):367-82. PubMed ID: 3304051 [TBL] [Abstract][Full Text] [Related]
39. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663 [TBL] [Abstract][Full Text] [Related]
40. [Intravenous substitution with immunoglobulins]. Zielinski CC; Eibl MM Wien Klin Wochenschr; 1991; 103(17):524-7. PubMed ID: 1949811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]